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Abstract
Knowledge of fetal nutrient supply has greatly increased in the last decade due to the availability of fetal blood samples
obtained under relatively steady-state conditions. These studies, together with studies utilizing stable isotope methodologies,
have clarified some aspects of the supply of the major nutrients for the fetus such as glucose, amino acids and fatty acids. At the
same time, the relevance of intrauterine growth has been recognized not only for the well-being of the neonate and child, but
also for later health in adulthood. The major determinants of fetal nutrient availability are maternal nutrition and metabolism
together with placental function and metabolism. The regulation of the rate of intrauterine growth is the result of complex
interactions between genetic inheritance, endocrine environment and availability of nutrients to the fetus.
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Introduction
Nutrition is one of the main factors that can affect fetal
development, growth and health. During intrauterine
life, determinants of fetal nutrition are quite different
from those involved in postnatal nutrition. In fact, in
developed countries nowadays people can choose what
to eat based on personal taste, commercial influence,
and also medical advice. Therefore, we consider
nutrition to be one of the habits that we can modify in
order to improve our quality of life.
However, fetuses themselves cannot choose what
to eat. Fetal nutrition is conditioned by different
processes that are not easily controlled and modified.
The fetus is nourished through the umbilical cord;
this “mix” is the result of maternal nutrition, meta-
bolism, endocrinology and of placental perfusion and
function [1].
Moreover, many factors influence fetal growth
throughout pregnancy: during this critical period the
nutritional and hormonal milieu may alter the expres-
sion of the fetal genome and this may have lifelong
consequences. These factors are able to induce long-
term adaptations in an individual through a process
that has been defined as “fetal programming” [2].
Based on this hypothesis, some critical periods are
thought to exist during fetal life, when the altered
expression of a number of genes would have lifelong
consequences [3]: perinatal growth, especially in the
case of intrauterine growth restriction (IUGR), has
pronounced effects on neonatal and adult health. For
this reason, the identification of factors playing a role in
normal and altered fetal growth can be useful for pre-
ventive measures.
Fetal nutrition is one of these factors: the complex
interaction between genetic growth potential, the
ability of the maternal–placental system to transfer
nutrients to the fetus and the endocrine environment
determine whether the fetus will follow its growth
potential during intrauterine life (Figure 1).
This review presents firstly an overview of the major
determinants of intrauterine growth together with fetal
nutrition, i.e. genetic inheritance and hormonal reg-
ulation, and then deals with the maternal and placental
factors determining fetal nutrition. Throughout the
review, data refer to human pregnancies studied
in vivo, although in some cases in vitro data are also
discussed.
Determinants of intrauterine growth
Genetic inheritance
Genetic inheritance is obviously one of the major
determinants of intrauterine growth. Recently,
increasing evidence supports that some genes, called
imprinted genes, are involved in promoting fetal
growth and that alterations in their expression are
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associated with impaired fetal growth [4]. An adequate
balance of maternal and paternal imprinted genes has
been shown to be required for placental implant and
fetal growth [5], and a genetic conflict hypothesis has
been advanced by Moore and Haig [6] to explain these
requirements. This hypothesis is based on the evidence
that most maternal expressed genes act as growth
suppressors whereas paternal expressed genes are
growth promoters, so that the father tends to promote
growth, while the mother controls the fetal demand for
nutrients. It is obvious that an imbalance in these
attitudes would alter fetal growth in, for example,
uniparental disomies (UPD), i.e. a chromosome pair
originating from one parent only. UPDs of a number
of chromosomes have been associated with specific
phenotypes, as is the case of maternal UPD7, which is
reported in 7% of cases of Silver-Russell syndrome,
with pre- and postnatal growth impairment [4].
Hormonal regulation
Hormones regulate intrauterine growth by acting on
the maternal compartment, placental development
and fetal metabolism. The hormonal regulation of
fetal growth during intrauterine life has not been
completely understood, but it seems pretty clear that
the main hormones involved are produced within the
placenta.
Insulin-like growth factors (IGFs) are involved in
fetal growth, as they are genetically old peptides that
induce cell proliferation and differentiation together
with DNA synthesis. Moreover, they increase glucose
and amino acid uptake, while simultaneously inhibiting
protein breakdown [7]. Although growth hormone
(GH) is the main regulator of IGF-I synthesis post-
natally, fetal tissues are relatively deficient in GH
receptors, suggesting that this hormone is of minor
importance during intrauterine development.
The endocrine unit of the placenta also produces a
specific growth hormone, placental growth hormone
(PGH), which has been characterized in the last 15 y
[8] and is the product of the GH-V gene expressed in
the syncytiotrophoblast. The secretion of PGH is
important in the control of maternal IGF-I levels.
Placental growth hormone secretion in the maternal
circulation has been shown to be significantly reduced
in pregnancies with fetal growth restriction, and this is
concomitant with the changes in IGF-I, thus support-
ing a critical role for placental GH and IGF-I in
determining fetal growth [9].
Leptin has raised great attention in recent years.
Leptin is a circulating polypeptide hormone, the pro-
duct of the ob gene which is expressed by adipocytes
[10]. Leptin levels have been measured in blood from
the umbilical cord of newborns, and a significant
relationship has been reported with fetal weight [11],
fetal BMI [12,13] and fetal fat mass [14]. Placental
production has also been demonstrated in vitro by the
detection of ob gene expression in placental tissues
[15]. Moreover, a study in the dually perfused placenta
produced evidence that most of the leptin produced by
the placenta is released into the maternal circulation,
but compared with other placental hormones, such as
chorionic gonadotropin and placental lactogen, a
considerably higher proportion of leptin is released into
the fetal circulation [16].
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Figure 1. Main determinants of fetal nutrition and growth.
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Fetal nutrition
When considering fetal nutrition, it is important
to keep in mind that pregnancy represents a three-
compartment model, with the mother, placenta and
fetus each presenting their own metabolism while
interacting with each other. Glucose, amino acids and
fatty acids are the most important nutrients in fetal life,
both for tissue deposition and as fuel for oxidative
purposes.
There is considerable experimental evidence sug-
gesting that, in the second half of gestation, fetal
growth is controlled by both maternal and placental
factors [17]. It is difficult to estimate the relative
influence of these two compartments in determining
the rate of intrauterine fetal growth. Both maternal and
placental factors are involved in alterations of fetal
growth rate, by changing the amount of nutrients
supplied to the fetus. Intrauterine growth restriction
is characterized by a reduced ability of the utero-
placental unit to supply oxygen and nutrients to the
fetus [18]. In gestational diabetes, on the other
hand, excess fetal growth seems to be derived from
the increased availability of maternal nutrients. The
increased fetal fat mass in these cases results from
the combined effects of this excess of nutrients
and the permissive environment of fetal hyper-
insulinaemia [19].
Maternal determinants
Maternal metabolism changes during pregnancy to
supply the feto-placental unit with all its nutritional
needs. A mother’s “adaptation to pregnancy” consists
of a number of changes that affect metabolism as well
as the function of the fetal placental unit through
haemodilution, reduction of peripheral resistances to
blood flow and reduction of blood pressure, most of all
within the placental district, and hormonal changes.
Maternal nutrition and metabolism vary further
during the course of pregnancy. The beginning of
pregnancy is characterized by storing substances
mainly within the adipose tissue: this is achieved
through maternal hyperphagia which, together with
endocrine changes, allows an increase in maternal net
body weight [20]. This is the period when the fetus is
very small but developing its organs and the quality of
the substrates obtained from the maternal circulation
prevails over quantity.
During the second part of gestation, the fetus grows
at an exponential rate and completes the structure of
important systems such as the central nervous system.
Nutritional needs increase: it has been estimated that,
in the term fetus, 40–50 kcal/kg/d are utilized for
tissue deposition, while 50 kcal/kg/d serve for oxidative
purposes [1].
The mother adapts her metabolism in order to
support the continuous draining of substrates by the
feto-placental unit: all the stores prepared at the
beginning of pregnancy are mobilized with this aim,
persist in the circulation for longer periods, and
accomplish a faster metabolism to make the trans-
placental passage easier. There is a marked increase in
blood glycerol, free fatty acids and keto acids induced
by fasting, even of a moderate degree, and this
phenomenon is known as “accelerated starvation of
pregnancy” [21].
Many studies have sought to link maternal nutrition
and metabolism to fetal growth. Some explanations
may be found at the extremes of normal conditions.
Maternal indices of insulin resistance, such as maternal
pre-pregnancy weight and maternal weight increase,
are related to fetal growth and birthweight [22]. The
effect of maternal undernutrition was studied during
the Dutch famine showing differences depending on
whether undernutrition occurred during the first or the
third trimester [23]. Birthweight was most affected in
the third trimester in women starving and acutely
hungry [24], whereas even moderate undernutrition in
the first trimester is associated with compensatory
placental growth [25].
In recent years, a number of studies have also sug-
gested that maternal nutrition in both quantitative and
qualitative terms may have long-term effects in
increasing the risk of diseases in adult life, and that the
effects are different depending on the gestational age of
occurrence [26,27]. Moreover, pregnancy is a period of
rapid growth and cell differentiation, when both the
mother and the fetus are very susceptible to alterations
in the dietary supply of nutrients. Maternal metabolism
should offer to the fetus a precise balance of substrates,
at the right time, according to different stages of
development.
Placental function
The fundamental role of the placenta in ensuring
normal fetal growth has been recognized both with
respect to its function in the fetal–maternal transfer
of nutrients, and also regarding its metabolic and
endocrine effects on the regulation of maternal and
fetal metabolism. The placenta is not only a passive
filter, its role is active, representing the main regulator
of fetal–placental metabolism.
Nutrients are transferred to the fetus by the placenta
through complex mechanisms involving transport sys-
tems present on the trophoblast microvillous and basal
membranes and on the endothelial membranes of fetal
capillaries. Moreover, extensive placental metabolism
has been demonstrated. Therefore, although the
maternal concentration is the main determinant of fetal
glucose, amino acid and fatty acid concentrations, the
placenta acts to determine the composition of the fetal
diet.
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Placental function varies through pregnancy so that
while at mid-gestation the placenta utilizes half of
its oxygen and glucose uptake and transfers the rest to
the fetal circulation, the proportion transferred to the
fetus increases with the progress of gestation [28,29].
In part, these changes are related to a large increase in
the fetal/placental mass ratio during gestation. More-
over, functional maturation of the placenta occurs
progressively through gestation, including significant
increases in total placental surface area and decreased
thickness [30], allowing increased nutrient transport
to meet the needs of advancing fetal growth. In addi-
tion, significant changes have been observed in the
activity of placental transport systems and in their
regulation [31].
A facilitated diffusion system is responsible for
maternal-to-fetal transfer of glucose, mediated by
members of the GLUT family, which are localized in
both maternal and fetal facing membranes [32]. The
primary isoform involved in the transplacental move-
ment of glucose is the GLUT1 glucose transporter,
responsible for glucose transport from mother to
placenta. Glucose transport from placenta to fetus
seems to be mediated by the GLUT3 protein, localized
on the vascular endothelium. In normal pregnancies,
fetal glucose concentrations are strictly dependent on
both maternal concentrations and gestational age [33],
with the placenta itself consuming a considerable
amount of glucose [29].
Placental amino acid transporters are protein
complexes within the maternal and fetal facing plasma
membranes. Amino acid placental transport is an
active, carrier-mediated process. Numerous amino
acid transporters have been characterized, mostly on a
functional basis, and some also on a molecular basis,
and each transports more than one amino acid [31].
The microvillous membrane (MVM) has several
transport systems, including system A, which is sodium
dependent and transports neutral amino acids such as
alanine, serine, proline and glycine. There are also
sodium-independent transport systems, such as system
L, for the branched-chain amino acids and phenyl-
alanine and system y+ for lysine.
In contrast, the mechanism of transport of fatty acids
across the placenta is not completely understood. The
placenta preferentially transports long-chain poly-
unsaturated fatty acids (LC-PUFAs), indicating an
important role of the placenta in handling the fatty acid
supply to the fetus [34,35]. Cellular uptake and intra-
cellular translocation of non-esterified fatty acids has
been proposed as a multistep process that is facilitated
by various membrane-associated and cytoplasmic
proteins [36]. Although all fatty acids can cross lipid
bilayers by simple diffusion, a number of fatty acid-
binding proteins (FABPs) have been identified that
seem to allow a bidirectional flux of fatty acids into and
out of cells. Essential fatty acids are mainly transported
to the placenta by non-esterified fatty acids carried
by triglycerides from lipoproteins from the maternal
adipose tissue and liver [20]. They are released by way
of lipoprotein lipase (LPL), the activity of which was
demonstrated in human placenta [37]. The placenta
also contains specific binding sites for lipoproteins
(VLDL, LDL, HDL) that carry esterified lipids [34].
The characteristics of placental fatty acid exchange are
represented in Figure 2. The placenta could also take
part in the elaboration, elongation and desaturation of
fatty acids, since the fatty acid profile in fetal blood is
different to that in maternal blood, with proportionally
higher amounts of long-chain polyunsaturated fatty
acids in fetal plasma [38]. Many questions remain to be
solved, however, since the enzymes involved in these
metabolic pathways have not been reported within the
placenta [39].
Fetal nutrients
The most important nutrients for the fetus are repre-
sented by glucose, amino acids and fatty acids together
with many micronutrients such as vitamins and ions.
During the last decade, a number of studies have
analysed the composition of fetal blood by in utero fetal
blood sampling. This relatively non-invasive procedure
has facilitated the study of the placental supply of
nutrients and the hormonal status of the fetus during
the second half of pregnancy [40].
By this means it has been possible to determine
the relationship between fetal and maternal glucose
concentrations from 18 wk to term [33]. In human
pregnancies, fetal glucose concentration decreases
during the second half of gestation depending on both
maternal glucose concentration and gestational age,
with fetal concentrations always lower than maternal
[33]. No significant glucogenesis has been demon-
strated in the fetal–placental unit, even in growth-
restricted fetuses [41].
In contrast, for most amino acids, no significant
changes have been observed at different gestational
ages, with fetal concentrations higher than maternal
concentrations [42]. However, studies performed in
human pregnancies in vivo by infusing stable isotopes
into the maternal circulation have demonstrated that,
for non-essential amino acids, fetal concentrations are
mostly obtained by production within the placenta,
from metabolically related amino acids [43]. For
glycine and serine and for glutamate and glutamine,
this is part of an inter-organ cycle between the placenta
and fetal liver [44].
Fatty acids represent a very good model of the
relationship between maternal diet and fetal growth
and wellness. The fetus needs mostly essential fatty
acids and their derivatives, arachidonic (n-6) and
docosahexaenoic (n-3) acid. Intrauterine requirements
for essential fatty acids (derivatives of n-6 and n-3)
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during the last trimester of pregnancy through to the
early weeks of life have been estimated to be 400 mg/
kg/d for n-6 and 50 mg/kg/d for n-3 [45]. LC-PUFAs
are rapidly incorporated into structural lipids of
the brain [46] where they maintain the fluidity, the
permeability and conformation of membranes and play
an important functional role in brain development and
visual function [47]. They are precursors of important
molecules such as prostaglandins, leukotrienes and
tromboxanes, and they also represent a source of
energy.
The incorporation of preformed arachidonic acid
(AA) and docosahexaenoic acid (DHA) into the
developing brain is selective and more than 10 times
faster than incorporation via the biosynthetic routes
from linoleic (LA) and a-linolenic acid (aLA) [48,49].
Although fatty acids supplied to the fetus are largely
determined by the fatty acid composition of the
maternal blood, the placenta is able to preferentially
transfer AA and DHA to the fetus, which is carried out
by means of a combination of several mechanisms, as
recently reviewed [34]. This has been described as a
process of “biomagnification”: the fetus shows higher
percentages of AA and DHA compared to the mother
[38], probably finalized to central nervous system
enrichment.
Fetal fatty acid plasma composition could also be
influenced by fatty acid metabolism in placental and
fetal tissues, but human placental tissue shows no
activity of either the D6- or D5-desaturases [39], and
although LC-PUFA synthesis from esterified fatty acid
precursors has been demonstrated to occur in preterm
infants as early as 26 wk gestation [50], other reports
have estimated that the contribution of endogenous
synthesis to the total plasma LC-PUFA pool in term
neonates is small [51].
From an energy point of view, fatty acids seem less
important at the beginning of pregnancy and instead
become of greater importance near delivery when they
represent an energy storage in adipose tissue. By
studying pregnancies at the time of in utero fetal blood
sampling, we have observed that saturated fatty acids
proportionally increase during pregnancy in fetal
plasma [38].
The role of micronutrients is essential at every stage
in fetal growth and development, although their study
is quite complicated due to interactions between them.
Retinoic acid is essential for signalling; others, like zinc,
are essential for stabilizing enzymes and transcription
factors or as central components of catalytic processes
(like copper and iron) [52]. Iron deficiency, besides
being associated with maternal anaemia and an
increased risk of maternal haemorrhage, has been
related to an increased placental/fetal weight ratio, a
predictor of cardiovascular disease in adulthood [3].
Amongst vitamins, the fat-soluble vitamins play an
important role for their antioxidant capacity, protect-
ing cells against damage induced by free radicals.
There is a complex interaction between n-3 and
n-6 fatty acids and fat-soluble vitamins. An excess
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Figure 2. Fatty acids: maternal metabolism and placental handling. NEFA: non-esterified fatty acids; TG: triglycerides; LPL: lipoprotein
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intake of polyunsaturated fatty acids (PUFAs) has
been shown to reduce antioxidant capacity [53].
The hyperlipidaemia characteristic of normal preg-
nancy during late gestation is associated with enhanced
LDL oxidation rate, although this effect is counter-
acted by increased oxidative resistance. The latter
probably occurs thanks to the enhanced levels of
vitamin E, although other antioxidant vitamins, such as
b-carotene and vitamin A, remain respectively stable or
decreased during normal pregnancy [54]. We have
recently described that, even in normal pregnancies,
there is a significant relationship between levels of fatty
acids and antioxidant vitamins [55]. These relation-
ships might influence placental function by reducing
placental perfusion or by altering the profile of cyto-
kines in the placenta, shifting the equilibrium towards
pro-inflammatory cytokines [56]. This imbalance at
the maternal–fetal interface may directly or indirectly
reduce the ability of the placenta to grow and function.
Conclusions
The adequacy of fetal nutrition is of utmost importance
for fetal growth and wellness. The relative needs of
different nutrients, however, are difficult to ascertain
and depend mainly on calculations obtained at birth or,
more recently, during the second half of pregnancy at
the time of in utero fetal blood sampling [40]. More-
over, fetal nutrition depends on both maternal and
placental factors that interact in complex ways.
Alterations in these factors may lead to changes in the
rate of fetal growth. For example, failure in maternal
adaptation and/or in trophoblast invasion in early
pregnancy can lead to intrauterine growth restriction: a
model in which nutrients become deficient because of
an alteration of the mechanism of the making and
functioning of the feto-placental unit [18].
In summary, fetal nutrition is not comparable to
adult nutrition because it is influenced by many factors
including maternal diet, maternal metabolism, adap-
tation to pregnancy, and predisposition to pathologies
that could affect normal placental development.
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